1. Home
  2. SLXN vs RSLS Comparison

SLXN vs RSLS Comparison

Compare SLXN & RSLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLXN
  • RSLS
  • Stock Information
  • Founded
  • SLXN 2008
  • RSLS 2002
  • Country
  • SLXN Israel
  • RSLS United States
  • Employees
  • SLXN N/A
  • RSLS N/A
  • Industry
  • SLXN
  • RSLS Medical/Dental Instruments
  • Sector
  • SLXN
  • RSLS Health Care
  • Exchange
  • SLXN NYSE
  • RSLS Nasdaq
  • Market Cap
  • SLXN 3.0M
  • RSLS 3.0M
  • IPO Year
  • SLXN N/A
  • RSLS 2007
  • Fundamental
  • Price
  • SLXN $0.21
  • RSLS $5.24
  • Analyst Decision
  • SLXN Strong Buy
  • RSLS Hold
  • Analyst Count
  • SLXN 1
  • RSLS 1
  • Target Price
  • SLXN $1.00
  • RSLS N/A
  • AVG Volume (30 Days)
  • SLXN 1.5M
  • RSLS 180.6K
  • Earning Date
  • SLXN 11-14-2024
  • RSLS 11-14-2024
  • Dividend Yield
  • SLXN N/A
  • RSLS N/A
  • EPS Growth
  • SLXN N/A
  • RSLS N/A
  • EPS
  • SLXN N/A
  • RSLS N/A
  • Revenue
  • SLXN N/A
  • RSLS $8,183,000.00
  • Revenue This Year
  • SLXN N/A
  • RSLS $17.47
  • Revenue Next Year
  • SLXN N/A
  • RSLS $20.00
  • P/E Ratio
  • SLXN N/A
  • RSLS N/A
  • Revenue Growth
  • SLXN N/A
  • RSLS N/A
  • 52 Week Low
  • SLXN $0.21
  • RSLS $4.60
  • 52 Week High
  • SLXN $13.56
  • RSLS $34.22
  • Technical
  • Relative Strength Index (RSI)
  • SLXN N/A
  • RSLS 42.38
  • Support Level
  • SLXN N/A
  • RSLS $4.88
  • Resistance Level
  • SLXN N/A
  • RSLS $5.89
  • Average True Range (ATR)
  • SLXN 0.00
  • RSLS 0.68
  • MACD
  • SLXN 0.00
  • RSLS 0.00
  • Stochastic Oscillator
  • SLXN 0.00
  • RSLS 17.80

About SLXN BIOMOTION SCIENCES

Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.

About RSLS ReShape Lifesciences Inc.

Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.

Share on Social Networks: